Denise M: Precision Hemostasis in Patient Blood Management
Denise M, Bloodless Medicine and Surgery Program Coordinator, shared a post on LinkedIn:
“Sometimes the best work begins with a challenge.
A few weeks ago, I posted an infographic on the value of Patient Blood Management (PBM) during a crisis.
Tomaz Crochemore, critical care physician and hemostasis expert, left a comment that stopped me.
He said the infographic was outstanding.
Then he pushed further. He wanted to see Patient Clot Management and precision hemostatic medicine explicitly woven into the PBM framework.
It was the first time I had heard of Patient Clot Management. While the physiology of bleeding and thrombosis including conditions like DIC is familiar territory in clinical practice, the term Patient Clot Management was new to me.
Crochemore’s work gave language and structure to that complexity.
I visited his profile (who is this guy?), and found his just published article in the Juntendo Medical Journal:
‘Revisiting the Concept of DIC: A Phenotype-guided Framework for Modern Hemostatic Medicine.’ That was my a-ha moment.
The dynamic balance between bleeding and thrombosis. Coagulopathy phenotyping. Individualized hemostatic therapy.
He was right. So I went to work.
What emerged is this:
Precision Hemostasis in Patient Blood Management.
A framework that moves beyond anemia and transfusion stewardship into the full spectrum of blood health:
- Identifying coagulopathy phenotypes — sepsis, trauma, cancer, obstetric, ECMO-induced
- Matching therapy to the patient’s actual hemostatic state
- Preventing both bleeding AND thrombosis
Not one-size-fits-all. Precision-guided. Patient at the center.
For me, it expanded how I think about the PBM framework and adds another dimension to the PBM conversation
Thank you, Crochemore, for seeing further and for trusting that a PBM nurse coordinator in Brooklyn would follow you there. It was great collaborating with you.
This infographic is proof. LinkedIn made it possible. ”

Stay updated with Hemostasis Today.
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda